نتایج جستجو برای: tumor vaccines

تعداد نتایج: 475750  

Journal: :Molecular cancer therapeutics 2012
Xu-Dong Tang Guo-Zhen Wang Jun Guo Mu-Han Lü Chuan Li Ning Li Ya-Ling Chao Chang-Zhu Li Yu-Yun Wu Chang-Jiang Hu Dian-Chun Fang Shi-Ming Yang

Accumulating research suggests that heparanase may be a universal tumor-associated antigen (TAA). Several heparanase T-cell epitopes from humans and mice have already been identified. However, because of low immunogenicity, polypeptide vaccines usually have difficulty inducing effective antitumor immune responses in vivo. In this study, to increase the immunogenicity of polypeptide vaccines, we...

Journal: :Oncology 1999
P I Haigh L A Difronzo G Gammon D L Morton

Investigation into the therapeutic use of vaccines in patients with metastatic melanoma is critically important because of the lack of effective conventional modalities. The most extensively studied melanoma vaccines in clinical trials are whole-cell preparations or cell lysates that contain multiple antigens capable of stimulating an immune response. Unfortunately, in the majority of studies, ...

Journal: :Journal of immunology 2001
J S Blanchet D Valmori I Dufau M Ayyoub C Nguyen P Guillaume B Monsarrat J C Cerottini P Romero J E Gairin

Intense efforts of research are made for developing antitumor vaccines that stimulate T cell-mediated immunity. Tumor cells specifically express at their surfaces antigenic peptides presented by MHC class I and recognized by CTL. Tumor antigenic peptides hold promise for the development of novel cancer immunotherapies. However, peptide-based vaccines face two major limitations: the weak immunog...

2012
Xu-Dong Tang Guo-Zhen Wang Jun Guo Chuan Li Ning Li Ya-Ling Chao Chang-Zhu Li Yu-Yun Wu Chang-Jiang Hu Dian-Chun Fang Shi-Ming Yang

Accumulating research suggests that heparanase may be a universal tumor-associated antigen (TAA). Several heparanase T-cell epitopes from humans and mice have already been identified. However, because of low immunogenicity, polypeptide vaccines usually have difficulty inducing effective antitumor immune responses in vivo. In this study, to increase the immunogenicity of polypeptide vaccines, we...

2011
Luigi Aurisicchio Gennaro Ciliberto

Therapeutic vaccination against cancer is an important approach which, when combined with other therapies, can improve long-term control of cancer. In fact, the induction of adaptive immune responses against Tumor Associated Antigens (TAAs) as well as innate immunity are important factors for tumor stabilization/eradication. A variety of immunization technologies have been explored in last deca...

2011
Genevieve M. Weir Robert S. Liwski Marc Mansour

Chemotherapy has been a mainstay in cancer treatment for many years. Despite some success, the cure rate with chemotherapy remains unsatisfactory in some types of cancers, and severe side effects from these treatments are a concern. Recently, understanding of the dynamic interplay between the tumor and immune system has led to the development of novel immunotherapies, including cancer vaccines....

2017
Jeremy M. Grenier Stephen T. Yeung Zhijuan Qiu Evan R. Jellison Kamal M. Khanna

Despite many years of research, cancer vaccines have largely been ineffective in the treatment of established cancers. Many barriers to immune-mediated destruction of malignant cells exist, and these likely limit the efficacy of cancer vaccines. In this study, we sought to enhance the efficacy of a cytomegalovirus (CMV)-based vaccine targeting melanoma by combining vaccination with other forms ...

Journal: :Cancer research 1997
J W Simons E M Jaffee C E Weber H I Levitsky W G Nelson M A Carducci A J Lazenby L K Cohen C C Finn S M Clift K M Hauda L A Beck K M Leiferman A H Owens S Piantadosi G Dranoff R C Mulligan D M Pardoll F F Marshall

Granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced, irradiated tumor vaccines induce potent, T-cell-mediated antitumor immune responses in preclinical models. We report the initial results of a Phase I trial evaluating this strategy for safety and the induction of immune responses in patients with metastatic renal cell carcinoma (RCC). Patients were treated in a randomize...

Journal: :Haematologica 2002
Pier Adelchi Ruffini Sattva S Neelapu Larry W Kwak Arya Biragyn

BACKGROUND AND OBJECTIVES Cancer vaccines are aimed at inducing tumor-specific immunity by immunizing patients with tumor cells or their antigenic components, known as tumor-associated antigens (TAA). Antigens which are either mutated or selectively or abundantly expressed in malignant, but not in normal, cells are considered as TAA. Each patient's B-cell malignancy is usually derived from a si...

2015
Yukino Kimura Yui Harada Noriko Yasuda Takefumi Ishidao Seiichi Yusa Keisuke Matsusaki Yoshikazu Yonemitsu

For the production of tumor-specific vaccines, including dendritic cell (DC) vaccines, the tumor cells themselves are an ideal source. Floating tumor cells in the ascites fluid from patients with malignant ascites are a good candidate source, but it is not easy to obtain pure tumor cells from ascites because of various types of cell contamination as well as protein aggregates. We here report an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید